Qurieno Deguchy Jr, MD in Carmichael, CA - Medicare Diagnostic Radiology

Qurieno Deguchy Jr, MD is a medicare enrolled "Radiology - Vascular & Interventional Radiology" physician in Carmichael, California. He went to University Of California, Davis School Of Medicine and graduated in 2015 and has 9 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Dignity Health Medical Foundation and his current practice location is 6305 Coyle Ave, Carmichael, California. You can reach out to his office (for appointments etc.) via phone at (916) 535-2000.

Qurieno Deguchy Jr is licensed to practice in California (license number A145262) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1053754671.

Contact Information

	Qurieno Deguchy Jr, MD
	6305 Coyle Ave, Carmichael, CA 95608-0438
	(916) 535-2000
	(916) 408-8000

Physician's Profile

Full Name	Qurieno Deguchy Jr
Gender	Male
Speciality	Diagnostic Radiology
Experience	9 Years
Location	6305 Coyle Ave, Carmichael, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Qurieno Deguchy Jr attended and graduated from University Of California, Davis School Of Medicine in 2015

NPI Data:

NPI Number: 1053754671
Provider Enumeration Date: 04/12/2013
Last Update Date: 08/31/2021

Medicare PECOS Information:

PECOS PAC ID: 0840621108
Enrollment ID: I20200520003632

Medical Identifiers

Medical identifiers for Qurieno Deguchy Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053754671	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2085R0204X	Radiology - Vascular & Interventional Radiology	A145262 (California)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Mercy San Juan Medical Center	Carmichael, CA	Hospital
Mercy General Hospital	Sacramento, CA	Hospital
Methodist Hospital Of Sacramento	Sacramento, CA	Hospital
Mercy Hospital Of Folsom	Folsom, CA	Hospital
Woodland Memorial Hospital	Woodland, CA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Dignity Health Medical Foundation	7810800661	1209

News Archive

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

Neogenix Oncology, Inc. (Neogenix) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's product candidate ensituximab (monoclonal antibody NPC-1C) for the treatment of pancreatic cancer. The Company initiated in December 2009 a multi-center Phase I clinical trial of ensituximab (NPC-1C) for the treatment of advanced pancreatic and colorectal cancer.

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

The U.S. Food and Drug Administration (FDA) has approved a new indication for FRAGMIN (dalteparin sodium injection), for the extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence of VTE in patients with cancer.

NHS hospitals in the North of England are performing better than those in the South

According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

CEL-SCI Corporation today announced that the Company held a clinical investigator meeting during the week of November 14th for its Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Qurieno Deguchy Jr allows following entities to bill medicare on his behalf.

Entity Name	Dignity Health Medical Foundation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1700803418 PECOS PAC ID: 7810800661 Enrollment ID: O20031107000709

News Archive

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

NHS hospitals in the North of England are performing better than those in the South

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

Entity Name	Regents Of The Univ Of Ca
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1013906973 PECOS PAC ID: 3375456619 Enrollment ID: O20031111000892

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

NHS hospitals in the North of England are performing better than those in the South

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Qurieno Deguchy Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Qurieno Deguchy Jr, MD 3400 Data Dr, Rancho Cordova, CA 95670-7956 Ph: () -	Qurieno Deguchy Jr, MD 6305 Coyle Ave, Carmichael, CA 95608-0438 Ph: (916) 535-2000

News Archive

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

NHS hospitals in the North of England are performing better than those in the South

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

Radiology Doctors in Carmichael, CA

Dr. Robert James Bemrick Ii, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6305 Coyle Ave, Carmichael, CA 95608 Phone: 916-961-6920 Fax: 916-966-5063
William Scott Cragun, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6305 Coyle Ave, Carmichael, CA 95608 Phone: 916-961-6946
Dr. Amardeep Singh Bhatia, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6305 Coyle Ave, Carmichael, CA 95608 Phone: 916-961-6920 Fax: 916-966-5063
Dr. Cindy Nguyen Sirois, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6305 Coyle Ave, Carmichael, CA 95608 Phone: 916-535-2000 Fax: 916-408-8000
Dr. Philip Oliver Haines, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 6305 Coyle Ave, Carmichael, CA 95608 Phone: 916-961-6920 Fax: 916-966-5063
Dr. Benjamin Kipper, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 6305 Coyle Ave, Carmichael, CA 95608 Phone: 916-535-2000 Fax: 916-408-8000

Qurieno Deguchy Jr, MD - Medicare Diagnostic Radiology in Carmichael, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

NHS hospitals in the North of England are performing better than those in the South

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

Medicare Reassignments

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

NHS hospitals in the North of England are performing better than those in the South

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

NHS hospitals in the North of England are performing better than those in the South

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Neogenix Oncology's ensituximab granted FDA orphan drug designation for pancreatic cancer treatment

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

NHS hospitals in the North of England are performing better than those in the South

CEL-SCI holds clinical investigator meeting for Multikine Phase III clinical trial in head, neck cancer

Radiology Doctors in Carmichael, CA